Degapride 120mg Injection is used for treating advanced hormone-dependent prostate cancer in adult men. It belongs to a class of medications known as gonadotropin-releasing hormone (GnRH) antagonists, which are categorised as antineoplastic medicines.
This medication is particularly beneficial when prostate cancer has reached an advanced stage but still depends on hormones for growth. By reducing testosterone levels in the body, this medicine helps slow down the growth of cancer cells that rely on this hormone to multiply, thereby restricting disease progression in hormone-dependent cases.
The injection must be administered by qualified healthcare professionals. Your doctor will determine the appropriate dosage and frequency based on your specific medical condition and response to treatment. Before beginning this treatment, inform your doctor about any pre-existing conditions such as heart disease, diabetes, liver problems, or allergic reactions to medications. Report any unusual symptoms or side effects promptly, and continue the treatment for the full duration prescribed by your doctor for optimal results.